Effect of Albendazole Dose on Clearance of Filarial Worms
Lymphatic Filariasis
About this trial
This is an interventional treatment trial for Lymphatic Filariasis focused on measuring Lymphatic Filariasis, Chemotherapy
Eligibility Criteria
INCLUSION CRITERIA (Screening): age 14 to 65. men and women*. Please note: women are not permitted to leave their homes at night without the approval of their husband or, if they are not married, a parent or male guardian. Since this protocol involves blood drawing at night, such approval is necessary for participation. EXCLUSION CRITERIA (Screening): non-volunteers. age less than 14 or greater than 65. pregnant by history. INCLUSION CRITERIA (Treatment): age 14 to 65 years. men and women.* Wb microfilarial count greater than or equal to 50 mf/ml. EXCLUSION CRITERIA (Treatment): non-volunteers. age less than 14 or greater than 65. pregnancy. Hgb less than 9 g/dl. Heavy alcohol use (more than 7 beer or other alcohol-containing drink/week). Temperature greater than 37.5C or other serious medical illnesses. history of benzimidazole allergy. history of ivermectin allergy. use of albendazole or ivermectin within the past 6 months.
Sites / Locations
- University of Bamako, Faculty of Medicine, Pharmacy and Odontostomatology